Conner Kenneth R, Pinquart Martin, Duberstein Paul R
University of Rochester Medical Center, Psychiatry, Rochester, NY 14642, USA.
Addiction. 2008 Apr;103(4):524-34. doi: 10.1111/j.1360-0443.2007.02118.x. Epub 2008 Feb 4.
To evaluate, among intravenous drug users (IDUs), the hypothesized positive association of depression with substance-related behaviors including concurrent drug use and impairment, future drug use and impairment, alcohol use and impairment, needle sharing and substance use treatment participation, and to identify moderators of these associations.
Meta-analysis of reports on IDUs published in English in peer-reviewed journals since 1986 that contained data on depression and substance use outcome(s) with no restrictions on range of depression scores to select the sample.
Fifty-five reports containing 55 samples met criteria, including 42 (76%) samples from clinical venues and 13 (24%) that were community-based.
Mean age was 34.3 (standard deviation = 4.5) years, comprising approximately 68% men and 43% white, non-Hispanic subjects.
Depression was assessed with the Beck Depression Inventory, Center for Epidemiological Studies Depression Scale (CES-D) and other validated scales or diagnostic interviews. The Addiction Severity Index was the most frequently used measure of substance-related outcomes.
A priori hypotheses pertaining to depression and the substance-related variables were supported, with the exception of the predicted association of depression and future drug use and impairment. Effect sizes were small. Moderating effects of gender were identified, including greater associations of depression with substance use treatment participation and needle sharing among women and a greater association of depression with future drug use and impairment among men. Effect sizes of moderators were large.
Depression is associated with several substance-related behaviors, and select associations are stronger according to gender. Prospective associations of depression with future drug use and impairment are not immediately evident, but could be examined in subsequent research.
在静脉注射吸毒者(IDU)中,评估抑郁症与物质相关行为之间假设的正相关关系,这些行为包括同时使用毒品及相关损害、未来的毒品使用及相关损害、酒精使用及相关损害、共用针头以及参与物质使用治疗,并确定这些关联的调节因素。
对1986年以来在同行评审期刊上发表的关于IDU的英文报告进行荟萃分析,这些报告包含抑郁症和物质使用结果的数据,对抑郁症评分范围无限制以选择样本。
55份报告包含55个样本符合标准,其中42个(76%)样本来自临床场所,13个(24%)为社区样本。
平均年龄为34.3岁(标准差 = 4.5),约68%为男性,43%为非西班牙裔白人。
使用贝克抑郁量表、流行病学研究中心抑郁量表(CES - D)以及其他经过验证的量表或诊断访谈来评估抑郁症。成瘾严重程度指数是最常用的物质相关结果测量方法。
除了抑郁症与未来毒品使用及相关损害的预测关联外,与抑郁症和物质相关变量的先验假设得到支持。效应量较小。确定了性别的调节作用包括抑郁症与女性物质使用治疗参与和共用针头之间的关联更强,以及抑郁症与男性未来毒品使用及相关损害之间的关联更强。调节因素的效应量较大。
抑郁症与多种物质相关行为有关,并且某些关联根据性别更强。抑郁症与未来毒品使用及相关损害的前瞻性关联并不立即明显,但可在后续研究中进行检验。